MERTK in the trigeminal system: a novel target for cluster headache and other headache disorders?

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

This study investigated whether MER proto-oncogene tyrosine kinase (MERTK) and its ligands are implicated in primary headache disorders, focusing on MERTK’s role in the trigeminal system in relation to cluster headache and migraine. Using immunohistochemistry in rat trigeminal ganglia (TG), RT-qPCR for MERTK gene expression in blood, and ELISA for serum levels of MERTK ligands, the authors found elevated MERTK gene expression in blood from cluster headache participants versus controls and increased serum Galectin-3 concentrations, while Growth Arrest Specific 6 and protein S were unchanged; both MERTK and Galectin-3 were expressed in TG, with Galectin-3 mainly in smaller neurons and MERTK in satellite glial cells and Schwann cell outer membranes. They report a particularly strong MERTK signal proximal to nodes of Ranvier, highlighting MERTK signaling as a potential therapeutic target. The paper is not explicitly peer-reviewed (preprint) and the abstract describes limited ligand panel validation beyond the measured serum markers. Relevance to endometriosis: the paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract The trigeminal system is key to the pathophysiology of migraine and cluster headache, two primary headache disorders that share many features. Recently, MER proto-oncogene tyrosine kinase (MERTK), a cell surface receptor, was strongly associated with cluster headache through genetic studies. Further, the MERTK ligand Galectin-3 has been found to be elevated in serum in migraine patients. In this study, MERTK and MERTK ligands were investigated in key tissue to better understand their potential implication in the pathophysiology of primary headache disorders. Immunohistochemistry was used to map MERTK and Galectin-3 expression in rodent trigeminal ganglia (TG). RT-qPCR was used to assess MERTK gene expression in blood and ELISA immunoassays were used for MERTK ligand quantification in serum from study participants with and without cluster headache. MERTK gene expression was elevated in blood samples from study participants with cluster headache patients as compared to controls. In addition, MERTK ligand Galectin-3 was found at increased concentration in the serum of study participants with cluster headache, while the ligands Growth Arrest Specific 6 and protein S levels were unaffected. MERTK and Galectin-3 were both expressed in rat TG. Galectin-3 was primarily located to smaller neurons and to a lesser extent in C-fibres, while MERTK was found in satellite glia cells (SGC) and in the outer membrane of Schwann cells. Interestingly, a strong MERTK signal was found specifically in the region proximal to the nodes of Ranvier. The overexpression of MERTK and Galectin-3 in study participants with cluster headache, as well as the presence of MERTK in peripheral SGC and Schwann cells in the TG, further highlights MERTK signalling as an interesting therapeutic target in primary headache.
Full text 15,980 characters · extracted from preprint-html · click to expand
MERTK in the trigeminal system: a novel target for cluster headache and other headache disorders? | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article MERTK in the trigeminal system: a novel target for cluster headache and other headache disorders? Jacob Carl Alexander Edvinsson, Lars Edvinsson, Caroline Ran, and 3 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4281019/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 22 May, 2024 Read the published version in The Journal of Headache and Pain → Version 1 posted 11 You are reading this latest preprint version Abstract The trigeminal system is key to the pathophysiology of migraine and cluster headache, two primary headache disorders that share many features. Recently, MER proto-oncogene tyrosine kinase (MERTK), a cell surface receptor, was strongly associated with cluster headache through genetic studies. Further, the MERTK ligand Galectin-3 has been found to be elevated in serum in migraine patients. In this study, MERTK and MERTK ligands were investigated in key tissue to better understand their potential implication in the pathophysiology of primary headache disorders. Immunohistochemistry was used to map MERTK and Galectin-3 expression in rodent trigeminal ganglia (TG). RT-qPCR was used to assess MERTK gene expression in blood and ELISA immunoassays were used for MERTK ligand quantification in serum from study participants with and without cluster headache. MERTK gene expression was elevated in blood samples from study participants with cluster headache patients as compared to controls. In addition, MERTK ligand Galectin-3 was found at increased concentration in the serum of study participants with cluster headache, while the ligands Growth Arrest Specific 6 and protein S levels were unaffected. MERTK and Galectin-3 were both expressed in rat TG. Galectin-3 was primarily located to smaller neurons and to a lesser extent in C-fibres, while MERTK was found in satellite glia cells (SGC) and in the outer membrane of Schwann cells. Interestingly, a strong MERTK signal was found specifically in the region proximal to the nodes of Ranvier. The overexpression of MERTK and Galectin-3 in study participants with cluster headache, as well as the presence of MERTK in peripheral SGC and Schwann cells in the TG, further highlights MERTK signalling as an interesting therapeutic target in primary headache. Trigeminal system MER proto-oncogene tyrosine kinase migraine GWAS Galectin-3 Full Text Additional Declarations No competing interests reported. Supplementary Files Suppli.Table1AntibodiesMERTK.docx GraphicalAbstract.tif Cite Share Download PDF Status: Published Journal Publication published 22 May, 2024 Read the published version in The Journal of Headache and Pain → Version 1 posted Editorial decision: Revision requested 02 May, 2024 Reviews received at journal 01 May, 2024 Reviews received at journal 23 Apr, 2024 Reviewers agreed at journal 22 Apr, 2024 Reviews received at journal 21 Apr, 2024 Reviewers agreed at journal 20 Apr, 2024 Reviewers agreed at journal 18 Apr, 2024 Reviewers invited by journal 17 Apr, 2024 Editor assigned by journal 17 Apr, 2024 Submission checks completed at journal 17 Apr, 2024 First submitted to journal 17 Apr, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4281019","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":293587545,"identity":"49effbd4-5623-4f4a-abbf-33130225ab50","order_by":0,"name":"Jacob Carl Alexander Edvinsson","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABDklEQVRIiWNgGAWjYBACxgYGBmYwzQwRkANiA4YHpGgxBmtJIGATM1QrGCQ2ENLC3H744eMCBhvZDcd5D3/8UXEnfW178waGxDYGe35cDutJMzaewZBmvOEwX5o0z5lnudvOHCsAaUmc2YBDS0MOmzQPw+HEmc08ZsyMbYdzt93IMQBpSTA4gENL/xuQlv8gLcYff7YdTje7/wasxd4el5YZYFsOJPYz8xhI8LYdTjC7wQPWwrgBl19mPAP6xSDZGKjFDOiXw4bbzqQVHEg4J5E4A4cthv3JwBCrsJNt4z9jDAyxw/Jmxw9vfPChzMaeH4f3DcHiBmiiQPMlcDiLgUEep8woGAWjYBSMAhgAAFRDWbNykt4dAAAAAElFTkSuQmCC","orcid":"","institution":"Lund University","correspondingAuthor":true,"prefix":"","firstName":"Jacob","middleName":"Carl Alexander","lastName":"Edvinsson","suffix":""},{"id":293587546,"identity":"1bd248ee-585f-49ce-96ee-991d780d720d","order_by":1,"name":"Lars Edvinsson","email":"","orcid":"","institution":"Lund University","correspondingAuthor":false,"prefix":"","firstName":"Lars","middleName":"","lastName":"Edvinsson","suffix":""},{"id":293587547,"identity":"50fee38c-53b2-42cd-acad-861de55d1e18","order_by":2,"name":"Caroline Ran","email":"","orcid":"","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Caroline","middleName":"","lastName":"Ran","suffix":""},{"id":293587548,"identity":"1eaa9d14-2f1b-4aa2-97c3-54819e8b4eb7","order_by":3,"name":"Felicia Jennysdotter Olofsgård","email":"","orcid":"","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Felicia","middleName":"Jennysdotter","lastName":"Olofsgård","suffix":""},{"id":293587549,"identity":"d6d5ce80-e446-47e9-8b1d-6a656463b3fd","order_by":4,"name":"Anna Steinberg","email":"","orcid":"","institution":"Karolinska University Hospital","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Steinberg","suffix":""},{"id":293587550,"identity":"77b35ea7-ed59-4082-b82d-35ec4e4112b7","order_by":5,"name":"Andrea Carmine Belin","email":"","orcid":"","institution":"Karolinska Institutet","correspondingAuthor":false,"prefix":"","firstName":"Andrea","middleName":"Carmine","lastName":"Belin","suffix":""}],"badges":[],"createdAt":"2024-04-17 09:50:14","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4281019/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4281019/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1186/s10194-024-01791-6","type":"published","date":"2024-05-23T00:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":58957367,"identity":"d6e30966-c7e2-4611-b514-d35e4e2ccf48","added_by":"auto","created_at":"2024-06-24 15:16:08","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":868663,"visible":true,"origin":"","legend":"","description":"","filename":"MERTKManuscriptFinal17april.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4281019/v1_covered_86b2400d-916a-4ee0-92fc-ff3f582fd770.pdf"},{"id":55057308,"identity":"b7f42a78-bd06-48f4-ad7a-6b479ffd6ef3","added_by":"auto","created_at":"2024-04-22 01:46:32","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":19615,"visible":true,"origin":"","legend":"","description":"","filename":"Suppli.Table1AntibodiesMERTK.docx","url":"https://assets-eu.researchsquare.com/files/rs-4281019/v1/14092262b507b273cfccf667.docx"},{"id":55057309,"identity":"20ce4368-cd1d-454b-914c-6ed957a7a332","added_by":"auto","created_at":"2024-04-22 01:46:32","extension":"tif","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":854400,"visible":true,"origin":"","legend":"","description":"","filename":"GraphicalAbstract.tif","url":"https://assets-eu.researchsquare.com/files/rs-4281019/v1/d51cd9dd404b9f993f041a2a.tif"}],"financialInterests":"No competing interests reported.","formattedTitle":"MERTK in the trigeminal system: a novel target for cluster headache and other headache disorders?","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"the-journal-of-headache-and-pain","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"tjhp","sideBox":"Learn more about [The Journal of Headache and Pain](https://thejournalofheadacheandpain.biomedcentral.com/)","snPcode":"10194","submissionUrl":"https://submission.nature.com/new-submission/10194/3","title":"The Journal of Headache and Pain","twitterHandle":"@BioMedCentral","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Trigeminal system, MER proto-oncogene tyrosine kinase, migraine, GWAS, Galectin-3","lastPublishedDoi":"10.21203/rs.3.rs-4281019/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4281019/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"The trigeminal system is key to the pathophysiology of migraine and cluster headache, two primary headache disorders that share many features. Recently, MER proto-oncogene tyrosine kinase (MERTK), a cell surface receptor, was strongly associated with cluster headache through genetic studies. Further, the MERTK ligand Galectin-3 has been found to be elevated in serum in migraine patients. In this study, MERTK and MERTK ligands were investigated in key tissue to better understand their potential implication in the pathophysiology of primary headache disorders.\nImmunohistochemistry was used to map MERTK and Galectin-3 expression in rodent trigeminal ganglia (TG). RT-qPCR was used to assess MERTK gene expression in blood and ELISA immunoassays were used for MERTK ligand quantification in serum from study participants with and without cluster headache.\nMERTK gene expression was elevated in blood samples from study participants with cluster headache patients as compared to controls. In addition, MERTK ligand Galectin-3 was found at increased concentration in the serum of study participants with cluster headache, while the ligands Growth Arrest Specific 6 and protein S levels were unaffected. MERTK and Galectin-3 were both expressed in rat TG. Galectin-3 was primarily located to smaller neurons and to a lesser extent in C-fibres, while MERTK was found in satellite glia cells (SGC) and in the outer membrane of Schwann cells. Interestingly, a strong MERTK signal was found specifically in the region proximal to the nodes of Ranvier.\nThe overexpression of MERTK and Galectin-3 in study participants with cluster headache, as well as the presence of MERTK in peripheral SGC and Schwann cells in the TG, further highlights MERTK signalling as an interesting therapeutic target in primary headache.","manuscriptTitle":"MERTK in the trigeminal system: a novel target for cluster headache and other headache disorders?","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-04-22 01:46:27","doi":"10.21203/rs.3.rs-4281019/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-05-02T08:14:05+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-05-01T21:03:30+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-04-23T18:46:53+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"03dfb0f9-d236-4986-88b1-50d8bc05c89c","date":"2024-04-23T02:15:05+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-04-22T03:50:07+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"228bbafb-42a7-4cd9-a4c2-1c7fba00f889","date":"2024-04-20T18:13:01+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"4b0ed8d6-194f-45e7-bcf4-6ed801b76a97_SNPRID","date":"2024-04-19T01:49:28+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-04-17T16:11:42+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-04-17T14:28:14+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-04-17T14:28:13+00:00","index":"","fulltext":""},{"type":"submitted","content":"The Journal of Headache and Pain","date":"2024-04-17T09:47:57+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"the-journal-of-headache-and-pain","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"tjhp","sideBox":"Learn more about [The Journal of Headache and Pain](https://thejournalofheadacheandpain.biomedcentral.com/)","snPcode":"10194","submissionUrl":"https://submission.nature.com/new-submission/10194/3","title":"The Journal of Headache and Pain","twitterHandle":"@BioMedCentral","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"9b697428-d017-4b7e-bea0-9538f7a9ad31","owner":[],"postedDate":"April 22nd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2024-06-24T15:16:03+00:00","versionOfRecord":{"articleIdentity":"rs-4281019","link":"https://doi.org/10.1186/s10194-024-01791-6","journal":{"identity":"the-journal-of-headache-and-pain","isVorOnly":false,"title":"The Journal of Headache and Pain"},"publishedOn":"2024-05-23 00:00:00","publishedOnDateReadable":"May 23rd, 2024"},"versionCreatedAt":"2024-04-22 01:46:27","video":"","vorDoi":"10.1186/s10194-024-01791-6","vorDoiUrl":"https://doi.org/10.1186/s10194-024-01791-6","workflowStages":[]},"version":"v1","identity":"rs-4281019","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4281019","identity":"rs-4281019","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0